Brain alterations in regions associated with end‐organ diabetic microvascular disease in diabetes mellitus: A UK Biobank study
Diabetes/Metabolism Research and Reviews · 2024
DOI: 10.1002/dmrr.3772 ↗At a glance
Multizentrische Studie in Diabetes/Metabolism Research and Reviews, 2024. Written by Jamie Burgess and 11 co-authors. Institution: Department of Cardiovascular & Metabolic Medicine and the Pain Research Institute, Institute of Life Course and Medical Sciences, University of Liver…. Major MEDLINE topics: Neurodegenerative Diseases, Diabetes Mellitus. Cited 7 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY 4.0). Funded by: Pain Relief Foundation.
Topics: Diabetes mellitus
Abstract (original language)
Background
Diabetes mellitus (DM) is associated with structural grey matter alterations in the brain, including changes in the somatosensory and pain processing regions seen in association with diabetic peripheral neuropathy. In this case‐controlled biobank study, we aimed to ascertain differences in grey and white matter anatomy in people with DM compared with non‐diabetic controls (NDC).
Methods
This study utilises the UK Biobank prospective, population‐based, multicentre study of UK residents. Participants with diabetes and age/gender‐matched controls without diabetes were selected in a three‐to‐one ratio. We excluded people with underlying neurological/neurodegenerative disease. Whole brain, cortical, and subcortical volumes (188 regions) were compared between participants with diabetes against NDC corrected for age, sex, and intracranial volume using univariate regression models, with adjustment for multiple comparisons. Diffusion tensor imaging analysis of fractional anisotropy (FA) was performed along the length of 50 white matter tracts.
Results
We included 2404 eligible participants who underwent brain magnetic resonance imaging (NDC, n = 1803 and DM, n = 601). Participants with DM had a mean (±standard deviation) diagnostic duration of 18 ± 11 years, with adequate glycaemic control (HbA1 C 52 ± 13 mmol/mol), low prevalence of microvascular complications (diabetic retinopathy prevalence, 5.8%), comparable cognitive function to controls but greater self‐reported pain. Univariate volumetric analyses revealed significant reductions in grey matter volume (whole brain, total, and subcortical grey matter), with mean percentage differences ranging from 2.2% to 7% in people with DM relative to NDC (all p < 0.0002). The subcortical (bilateral cerebellar cortex, brainstem, thalamus, central corpus callosum, putamen, and pallidum) and cortical regions linked to sensorimotor (bilateral superior frontal, middle frontal, precentral, and postcentral gyri) and visual functions (bilateral middle and superior occipital gyri), all had lower grey matter volumes in people with DM relative to NDC. People with DM had significantly reduced FA along the length of the thalamocortical radiations, thalamostriatal projections, and commissural fibres of the corpus callosum (all; p < 0·001).
Interpretation
This analysis suggests that anatomic differences in brain regions are present in a cohort with adequately controlled glycaemia without prevalent microvascular disease when compared with volunteers without diabetes. We hypothesise that these differences may predate overt end‐organ damage and complications such as diabetic neuropathy and retinopathy. Central nervous system alterations/neuroplasticity may occur early in the natural history of microvascular complications; therefore, brain imaging should be considered in future mechanistic and interventional studies of DM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiovascular & Metabolic Medicine and the Pain Research Institute, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
- Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
- Department of Pain Medicine, The Walton Centre, Liverpool, UK.
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
- Department of Biostatistics, University of Liverpool, Liverpool, UK.
- Faculty of Life Sciences and Medicine, King's College London, London, UK.
ORCID profiles: Jamie Burgess
Funding
- Pain Relief Foundation
Cite
APA
Burgess, J., de Bezenac, C., Keller, S. S., Frank, B., Petropoulos, I. N., Garcia-Finana, M., Jackson, T. L., Kirthi, V., Cuthbertson, D. J., Selvarajah, D., Tesfaye, S., & Alam, U. (2024). Brain alterations in regions associated with end‐organ diabetic microvascular disease in diabetes mellitus: A UK Biobank study. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3772
Vancouver
Burgess J, de Bezenac C, Keller SS, Frank B, Petropoulos IN, Garcia-Finana M, et al. Brain alterations in regions associated with end‐organ diabetic microvascular disease in diabetes mellitus: A UK Biobank study. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3772
BibTeX
@article{Burgess2024,
author = {Burgess, Jamie and de Bezenac, Christophe and Keller, Simon S and Frank, Bernhard and Petropoulos, Ioannis N and Garcia-Finana, Marta and Jackson, Timothy L and Kirthi, Varo and Cuthbertson, Daniel J and Selvarajah, Dinesh and Tesfaye, Solomon and Alam, Uazman},
title = {Brain alterations in regions associated with end‐organ diabetic microvascular disease in diabetes mellitus: A UK Biobank study},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2024},
doi = {10.1002/dmrr.3772}
}
EUVIMED